RT Journal Article
SR Electronic
T1 Prevalence of Post COVID-19 Condition among healthcare workers: self-reported online survey in four African countries
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.06.22.23291768
DO 10.1101/2023.06.22.23291768
A1 Elnadi, Hager
A1 Al-Mustapha, Ahmad I.
A1 Odetokun, Ismail A.
A1 Anjorin, AbdulAzeez Adeyemi
A1 Mosbah, Rasha
A1 Fasina, Folorunso O.
A1 Razouqi, Youssef
A1 Awiagah, Kwame Sherrif
A1 Nyandwi, Jean Baptiste
A1 Mhgoob, Zuhal E.
A1 Gachara, George
A1 Mohamud, Mohamed Farah Yusuf
A1 Damaris, Bamu F.
A1 Maisara, Aala MohamedOsman
A1 Radwan, Mona
YR 2023
UL http://medrxiv.org/content/early/2023/06/29/2023.06.22.23291768.abstract
AB The impact of Post COVID-19 Condition is ongoing despite the WHO declaration that the pandemic has ended. In this study, we explore the prevalence of PCC among healthcare workers (HCWs) in four African Countries and its influence on their professional performance. This study was conducted as an online cross-sectional survey of healthcare workers from four African countries (Cameroon, Egypt, Nigeria, and Somalia) between the 20th of December 2021 to 12th of January 2022. We determined the prevalence of PCC based on the WHO case definition and assessed variables associated with a higher prevalence of PCC in these countries using univariable and multivariable logistic regression analyses. A total of 706 HCWs from four African countries were included in this survey. Most of the HCWs were aged between 18-34 years (75.8%, n=535). Our findings showed that 19.5% (n=138) of the HCWs had tested positive for SARS-CoV-2. However, 8.4% (n=59) were symptomatic for COVID-19 but tested negative or were never tested. Two-thirds of the HCWs (66.4%, n=469) have received a COVID-19 vaccine and 80.6% (n=378) of those vaccinated had been fully vaccinated. The self-reported awareness rate of PCC among the HCWs was 16.1% (n=114/706) whereas the awareness rate of PCC among COVID-19-positive HCWs was 55.3 % (n=109/197). The prevalence of PCC among HCWs was 58.8% (n=116). These changes include the self-reported symptoms of PCC which included headache (58.4%, n=115), fatigue (58.8%, n=116), and muscle pain (39.6%, n=78). Similarly, 30% (n=59) and 20.8% (n=41) of the HCWs reported the loss of smell and loss of taste long after their COVID-19 infection, respectively. Some HCWs (42%, n=83) believed that their work performance has been affected by their ongoing symptoms of PCC. There was no significant difference in the prevalence of PCC among the vaccinated and unvaccinated HCWs (p > 0.05). Of the socio-demographic variables, age (older HCWs between 45-54 years; OR:1.7; 95% CI: 1.06, 10.59; p = 0.001) and location (Egypt; OR:14.57; 95% CI: 2.62, 26.76; p = 0.001) were more likely to have experienced PCC than other age groups and countries respectively. The study revealed low prevalence of PCC among the surveyed HCC. In addition, it observed the need for adequate medical and psychological support to HCWs with PCC, improve their COVID-19 vaccination uptake, and conduct mass advocacy campaigns on PCC.COVID-19 positivity rate (n =197), vaccination rate (n =706), PCC awareness rate (n = 114), and prevalence of PCC (n = 116) in HCWs across four African countries.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The ethical clearance for this study was obtained from the Kwara State Ministry of Health, Ilorin, Nigeria with reference number MOH/KS/EHC/777/502 as well as the ethical review board of the Faculty of Human Medicine of the University of Zagazig, Egypt (Reference 134 number: ZU-IRB #9241/2-1-2022). We obtained written informed consent from each respondent after brief information on the purpose of the study was provided to them. To participate in the study, a respondent must tick the consent box in the mobile application (ODK). Participation in this survey was voluntary and without prejudice, as participants could withdraw from the survey at any time.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors